Objective To investigate the safety and feasibility of the total mesorectal excision （TME） and intersphincteric resection （ISR） for ultra-low rectal cancer and anal sphincter preservation surgery for anorectal cancer， and to evaluate the short term efficacy and postoperative anal function. Methods A retrospective analysis of clinical and follow-up data of 86 cases with TME＋ISR for ultra-low rectal cancer and anorectal cancer from January 2009 to December 2010 in West China Hospital of Sichuan University were performed. Results Eighty-six patients were successfully performed the operation， the lower edge of tumor from the anus was 1-5 cm （average 1.63cm）； tumor diameter was 2-7 cm （average 3.4cm）. The tumors were high differentiation in 4 cases， moderately differentiation in 60 cases，and poorly differentiation in 22 cases. The pTNM stages were stageⅠin 12 cases， stageⅡA in 11 cases， stage ⅡB in 15 cases， stage ⅢA in 2 cases， stage ⅢB in 23 cases， stage ⅢC in 16 cases， and stage Ⅳ in 7 cases. There were postoperative anastomotic leakage in 3 cases， perianal infection in 2 cases （1 case received reoperation with permanent colostomy because of pelvic peritoneal infection caused by perianal severe infections）. Anastomotic bleeding and anastomotic stenosis were of 2 cases respectively. Rectovaginal fistula， inflammatory ileus， urinary retention， and abdominal infection were of 1 case respectively. Eighty-six patients were followed-up for 12-24 months， the mean time was 18 months. Liver metastases was found in 1 case in 7 months after operation， 2 cases dead in the 7th month and 12th month after operation respectively. Local recurrence were found in 3 cases （3.5%） in 1 year after operation. The survival rate of 1-year was 97.7% （84/86）. The times of defecation was 1-5 times a day. The Kirwan’s score level on function of control defecation was 1-2 grade. Conclusions TME＋ISR for low rectal cancer and anorectal cancer is a viable， safe， and radical operation type for preservation of anus. The short term efficacy is satisfactory.
目的 探讨肛管拖出式双吻合器在超低位直肠癌保肛手术中的应用价值。方法 回顾性总结我院23例超低位直肠癌保肛手术的经验。结果 本组病例利用肛管拖出和双吻合器技术行超低位保肛术均获成功，术后发生吻合口漏1例（4.3%），切口感染2例（8.7%），术后局部复发2例（8.7%），无手术死亡。结论 肛管拖出式双吻合器技术行超低位保肛术是安全可靠的，它可以大大提高超低位直肠癌保肛手术的成功率。
Objective To evaluate the role of curved-cutter-stapler in anus-preserving for low rectal cancer. Methods The clinical data of 32 patients with low rectal cancer from June 2007 to December 2008 who received low anterior resection and ultra low anterior resection by using curved-cutter-stapler were reviewed retrospectively. Results No operation death case, complete cutting and safe closure in all cases, one case was complicated with anastomotic leakage, and one case of rectovaginal fistula. Thirty patients were followed up 4 to 22 months after the operation, with an average time of 12.6 months, no hemorrhea of pelvic cavity and anastomotic stoma or anastomotic stenosis cases. Conclusion Curved-cutter-stapler has the advantages of complete cutting, safe closure and low complications, and easy being used in anus-preserving operation for low rectal cancer, which can increase the rate of anus-preserving.
直肠癌是临床常见的恶性肿瘤之一，手术切除仍是目前治疗直肠癌的重要手段，Miles手术经历近100年的历史，已成为治疗直肠癌的金标准。当Miles手术推行半个世纪以后，人们开始对该手术需做永久性腹部结肠造口，给患者带来精神上的负担、生活和社交上的不便而引起重视。近年来，随着国民经济的发展和人民生活水平的不断提高，人们越来越重视在保住生命的同时，更要求有良好的生活质量。随着对直肠癌的解剖、病理、生物学特性及淋巴结转移规律的深入研究和探索，提出了新的概念、新的理论、新的观点和新的术式，使保留肛门括约肌功能的直肠癌根治术逐年增多，约占直肠癌外科手术的70%。保肛术式的发展逐渐取代了Miles手术，可显著提高患者的生活质量。目前直肠癌的外科治疗在知识创新和技术创新的推动下已进入一个蓬勃发展的阶段。
目的 探讨国产单吻合器在低位直肠癌保肛手术中的临床应用效果。方法 结合相关文献回顾性分析2003年1月至2007年12月期间我院收治的128例低位直肠癌中行直肠全系膜切除（TME）且应用国产管状吻合器及荷包钳进行手术的91例患者的资料。结果 全组无手术死亡病例，保肛均获成功，保肛率为71.09%（91/128），术后病理检查肿瘤远端切缘无癌残留。未发生吻合口出血及狭窄； 1例（1.10%）发生吻合口漏，经保守治疗后痊愈； 无大便失禁发生。全组获随访1～5年，平均3.8年，局部复发6例（6.59%）； 总的1年生存率为97.80%（89/91），3年生存率为80.00%（72/90），5年生存率为68.97%（60/87）。结论 TME联合国产管状吻合器及荷包钳应用于低位直肠癌根治术，可提高保肛率，操作简单安全，疗效满意。